In an MDA-5 amyopathic dermatomyositis–ILD patient, adding MMF (1.5 g/day) improved PF ratio and lowered FGF-2, CX3CL1, IL-1ra, IL-17A, IP-10 and MCP-1 [110]. Here, IL17A is linked to interstitial lung disease.